KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Cvs Health (CVS) Long-Term Debt Issuances (2018 - 2025)

Cvs Health's Long-Term Debt Issuances history spans 10 years, with the latest figure at $4.0 billion for Q3 2025.

For the quarter ending Q3 2025, Long-Term Debt Issuances changed N/A year-over-year to $4.0 billion, compared with a TTM value of $6.9 billion through Dec 2025, down 12.51%, and an annual FY2025 reading of $4.0 billion, down 49.84% over the prior year.
Long-Term Debt Issuances for Q3 2025 was $4.0 billion at Cvs Health, up from $3.0 billion in the prior quarter.
The five-year high for Long-Term Debt Issuances was $6.0 billion in Q1 2023, with the low at $987.0 million in Q3 2021.
Average Long-Term Debt Issuances over 4 years is $4.0 billion, with a median of $4.5 billion recorded in 2023.
Year-over-year, Long-Term Debt Issuances tumbled 75.16% in 2021 and then increased 0.24% in 2024.
Tracing CVS's Long-Term Debt Issuances over 4 years: stood at $987.0 million in 2021, then soared by 401.22% to $4.9 billion in 2023, then tumbled by 40.29% to $3.0 billion in 2024, then surged by 34.36% to $4.0 billion in 2025.
Per Business Quant, the three most recent readings for CVS's Long-Term Debt Issuances are $4.0 billion (Q3 2025), $3.0 billion (Q4 2024), and $5.0 billion (Q2 2024).